Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Schandené

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Clinical and Experimental Immunology|September 1, 1985
In vitro correction of the interleukin-2 and interferon-gamma defect in multiple sclerosisG Vervliet, L Schandené
Clinical Immunology (Orlando, Fla.)|January 11, 2011
Are the reference values of B cell subpopulations used in adults for classification of common variable immunodeficiencies appropriate for children?J Smet, F Mascart, L Schandené
La Revue Du Praticien|May 16, 2000
[Chronic hypereosinophilia: a model of Th2 disorders]F Roufosse, L Schandené, E Cogan, et al.
Clinical Immunology and Immunopathology|August 1, 1983
Active T rosettes, human autologous T rosettes, OKT8 and OKT4 cells, con A-induced suppressive activity, and autoantibodies: clinical correlationsL Schandené, F Vanden Steen, F Romasco, et al.
Drugs of Today (Barcelona, Spain : 1998)|March 11, 2004
The idiopathic hypereosinophilic syndrome: clinical presentation, pathogenesis and therapeutic strategiesF Roufosse, E Bartholomé, L Schandené, et al.
Molecular Immunology|March 1, 1995
Spontaneous and cycloheximide-induced interleukin-10 mRNA expression in human mononuclear cellsP Stordeur, L Schandené, P Durez, et al.
Transplantation|February 1, 1985
Influence of in vivo immunosuppressive drugs on production of lymphokinesE Dupont, K Huygen, L Schandené, et al.
Clinical and Experimental Immunology|April 20, 2011
Cellular immune responses in human immunodeficiency virus (HIV)-1-infected children: is immune restoration by highly active anti-retroviral therapy comparable to non-progression?M Hainaut, V Verscheure, M Ducarme, et al.
European Journal of Immunology|April 12, 2001
Clonal Th2 cells associated with chronic hypereosinophilia: TARC-induced CCR4 down-regulation in vivoA de Lavareille, F Roufosse, L Schandené, et al.
Acta Neurologica Belgica|April 28, 1999
Interferon-beta inhibits Th1 responses at the dendritic cell level. Relevance to multiple sclerosisE J Bartholomé, F Willems, A Crusiaux, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Clinical and Experimental Immunology|September 1, 1985
In vitro correction of the interleukin-2 and interferon-gamma defect in multiple sclerosisG Vervliet, L Schandené
Clinical Immunology (Orlando, Fla.)|January 11, 2011
Are the reference values of B cell subpopulations used in adults for classification of common variable immunodeficiencies appropriate for children?J Smet, F Mascart, L Schandené
La Revue Du Praticien|May 16, 2000
[Chronic hypereosinophilia: a model of Th2 disorders]F Roufosse, L Schandené, E Cogan, et al.
Clinical Immunology and Immunopathology|August 1, 1983
Active T rosettes, human autologous T rosettes, OKT8 and OKT4 cells, con A-induced suppressive activity, and autoantibodies: clinical correlationsL Schandené, F Vanden Steen, F Romasco, et al.
Drugs of Today (Barcelona, Spain : 1998)|March 11, 2004
The idiopathic hypereosinophilic syndrome: clinical presentation, pathogenesis and therapeutic strategiesF Roufosse, E Bartholomé, L Schandené, et al.
Molecular Immunology|March 1, 1995
Spontaneous and cycloheximide-induced interleukin-10 mRNA expression in human mononuclear cellsP Stordeur, L Schandené, P Durez, et al.
Transplantation|February 1, 1985
Influence of in vivo immunosuppressive drugs on production of lymphokinesE Dupont, K Huygen, L Schandené, et al.
Clinical and Experimental Immunology|April 20, 2011
Cellular immune responses in human immunodeficiency virus (HIV)-1-infected children: is immune restoration by highly active anti-retroviral therapy comparable to non-progression?M Hainaut, V Verscheure, M Ducarme, et al.
European Journal of Immunology|April 12, 2001
Clonal Th2 cells associated with chronic hypereosinophilia: TARC-induced CCR4 down-regulation in vivoA de Lavareille, F Roufosse, L Schandené, et al.
Acta Neurologica Belgica|April 28, 1999
Interferon-beta inhibits Th1 responses at the dendritic cell level. Relevance to multiple sclerosisE J Bartholomé, F Willems, A Crusiaux, et al.
Pageof 3